^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

FCN-098

i
Other names: FCN-098
Company:
Fosun Pharma
Drug class:
Trk inhibitor
over2years
Study of FCN-098 in Patients With Advanced Solid Tumor (clinicaltrials.gov)
P1, N=43, Recruiting, Fochon Pharmaceuticals, Ltd.
New P1 trial
|
NTRK (Neurotrophic receptor tyrosine kinase)
|
NTRK positive • NTRK fusion
|
FCN-098